The company said the results of a planned interim analysis met prespecified criteria for early termination of the study. "They did not meet the high-bar efficacy we established for advancing our ...
Johnson & Johnson said on Friday it discontinued a mid-stage study of its experimental drug to treat patients with moderate ...
Iron deficiency without anemia is a common feature of moderate-to-severe atopic dermatitis (AD), according to a study ...
The top 5 most-read dermatology content of 2025 on AJMC.com included innovative advances from artificial intelligence ...
Gadgets are now a part of the everyday routine for us. Tablets, phones, and laptops not only tend to affect the posture and ...
A recent study revealed that iron deficiency without anemia is common among adults with moderate-to-severe atopic dermatitis ...
Seborrheic dermatitis is associated with other epithelial barrier diseases of the skin and beyond, including the respiratory, ...
Nemolizumab, which targets the interleukin-31 pathway, rapidly improves itch and sleep in people with atopic dermatitis and ...
Here are our top highlights from AAD 2025 that include safety of topical JAK inhibitors, climate impacts on skin health, ...
Dermatitis herpetiformis is a bumpy, very itchy skin rash that’s caused by gluten sensitivity. In fact, about 10%-25% of people with celiac disease get dermatitis herpetiformis. Celiac disease is an ...
Libtayo's approval for high-risk cutaneous squamous cell carcinoma offers a new immunotherapy option, targeting PD-1 ...
Contact dermatitis is a rash that crops up on your skin when you touch or have a reaction to a certain substance. It’s red, itchy, and uncomfortable, but it’s not life-threatening. The rash could be ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback